Received Sep 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 3 | — | — |
No side effects or symptoms reported; Physician called to report a set of twins got the GARDASIL 9 vaccine and didn't follow the recommended schedule, Male patient had initial dose 6/27/2024, second dose 1/8/2025 (7 months later) and third dose 3/12/2025 (2 months later).; This spontaneous report was received from a physician and referred to a male patient of unknown age. The patient's medical history, concurrent condition, and concomitant therapy were not reported. On 27-Jun-2024 (when the patient was 17 years old), the patient vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, does, frequency, route, lot # and expiration date were not reported) for prophylaxis. On 08-Jan-2025, the patient vaccinated with the second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, does, frequency, route, lot # and expiration date were not reported) for prophylaxis. On 12-Mar-2025, the patient vaccinated with the third dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, does, frequency, route, lot # and expiration date were not reported) for prophylaxis (Inappropriate schedule of vaccine administered). No side effects or symptoms reported. Lot# is being requested and will be submitted if received. This is one of two cases from the same reporter.